Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: Insights from an integrated single-cell RNA and bulk RNA sequencing study
PLOS One · 01.12.2025 · 20 (12) · e0337175
DOI: 10.1371/journal.pone.0337175 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 01.12.2025. Verfasst von Bin Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Breast Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Macrophages, Chemokine CXCL9. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Breast cancer is the most common cancer among women and a leading contributor to disease-related mortality. While advancements in diagnostic techniques and the widespread dissemination of medical knowledge have improved outcomes, immunotherapy targeting the tumor microenvironment offers a promising approach to further reducing the disease burden.
Methods
We first explored cellular heterogeneity within breast cancer tumors using single-cell RNA sequencing and subsequently analyzed the association between the infiltration levels of various cell types and survival prognosis using a deconvolution algorithm combined with bulk RNA sequencing. Our analysis identified CXCL9 + macrophages as being associated with improved survival outcomes. Next, WGCNA was used to identify genes related to CXCL9 + macrophage infiltration, and a survival risk model was constructed based on these genes. Finally, experiments were conducted to validate the effects of CXCL9 + macrophages on breast cancer cells.
Results
We found that CXCL9 + macrophage primarily interacted with cytokines and activated T and NK cells through the CXCL9/10/11-CXCR3 axis. Increased infiltration, as observed in bulk RNA sequencing, was associated with improved patient survival. The risk model constructed based on CXCL9 + macrophage infiltration-related genes demonstrated strong efficacy in predicting patient survival outcomes. Finally, in vitro experiments confirmed that CXCL9 + macrophages inhibited the viability of breast cancer cells.
Conclusion
CXCL9 + macrophages could play a significant role in inhibiting breast cancer, and their infiltration into tumor tissues is associated with improved survival in breast cancer patients. Immunotherapy targeting CXCL9 + macrophages hold great potential as a therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery (Breast Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
- Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
ORCID-Profile: Peng Zhou
Zitieren
APA
Liang, B., Duan, Z., Long, S., & Zhou, P. (2025). Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: Insights from an integrated single-cell RNA and bulk RNA sequencing study. PLOS One, 20(12), e0337175. https://doi.org/10.1371/journal.pone.0337175
Vancouver
Liang B, Duan Z, Long S, Zhou P. Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: Insights from an integrated single-cell RNA and bulk RNA sequencing study. PLOS One. 2025;20(12):e0337175. doi:10.1371/journal.pone.0337175
BibTeX
@article{Liang2025,
author = {Liang, Bin and Duan, Zhicai and Long, Siyu and Zhou, Peng},
title = {Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: Insights from an integrated single-cell RNA and bulk RNA sequencing study},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {12},
pages = {e0337175},
doi = {10.1371/journal.pone.0337175}
}
EUVIMED